Last updated on November 2018

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

Brief description of study

The purpose of this study is to test the safety of the study drug, atezolizumab, when combined with the standard chemotherapy drugs, gemcitabine and cisplatin (or GC). This study will help researchers begin to understand whether combining GC with atezolizumab is better, the same, or worse than the usual approach of using GC alone.

Clinical Study Identifier: NCT02989584

Contact Investigators or Research Sites near you

Start Over

Samuel Funt, MD

Memoral Sloan Kettering Westchester
Harrison, NY United States
  Connect »